232 related articles for article (PubMed ID: 3022629)
21. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic insuloma causing Cushing's syndrome.
Torriani F; Uske A; Temler E; Rey F; Hurlimann J; Delaloye B; Gomez F
J Endocrinol Invest; 1989 May; 12(5):313-9. PubMed ID: 2549115
[TBL] [Abstract][Full Text] [Related]
23. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
[TBL] [Abstract][Full Text] [Related]
24. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of the corticotropin-releasing hormone test during bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's disease.
Tabarin A; Greselle JF; San-Galli F; Leprat F; Caille JM; Latapie JL; Guerin J; Roger P
J Clin Endocrinol Metab; 1991 Jul; 73(1):53-9. PubMed ID: 1646218
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
[TBL] [Abstract][Full Text] [Related]
27. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.
Hensen J; Buhl M; Bähr V; Oelkers W
Klin Wochenschr; 1990 Jun; 68(12):608-14. PubMed ID: 2165544
[TBL] [Abstract][Full Text] [Related]
28. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
29. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity.
Grossman A; Howlett TA; Kopelman PG
Horm Metab Res Suppl; 1987; 16():62-4. PubMed ID: 2832293
[TBL] [Abstract][Full Text] [Related]
30. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
[TBL] [Abstract][Full Text] [Related]
31. [Corticotropin releasing factor as an aid in the diagnosis of Cushing syndrome].
Pirich K; Vierhapper H; Nowotny P
Wien Klin Wochenschr; 1985 Nov; 97(21):806-8. PubMed ID: 2998101
[TBL] [Abstract][Full Text] [Related]
32. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.
Mengden T; Hubmann P; Müller J; Greminger P; Vetter W
Clin Investig; 1992 Jul; 70(7):545-8. PubMed ID: 1327327
[TBL] [Abstract][Full Text] [Related]
33. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.
Bruno OD; Rossi MA; Contreras LN; Gómez RM; Galparsoro G; Cazado E; Kral M; Leber B; Arias D
Acta Endocrinol (Copenh); 1985 Jun; 109(2):158-62. PubMed ID: 2990131
[TBL] [Abstract][Full Text] [Related]
34. Cushing's syndrome: a review of diagnostic tests.
Crapo L
Metabolism; 1979 Sep; 28(9):955-77. PubMed ID: 225638
[TBL] [Abstract][Full Text] [Related]
35. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome.
Raff H; Findling JW
Clin Chem; 1989 Apr; 35(4):596-600. PubMed ID: 2539271
[TBL] [Abstract][Full Text] [Related]
36. Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test.
Biemond P; de Jong FH; Lamberts SW
Ann Intern Med; 1990 May; 112(10):738-42. PubMed ID: 2158760
[TBL] [Abstract][Full Text] [Related]
37. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
Engelhardt D; Jacob K; Doerr HG
Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
[TBL] [Abstract][Full Text] [Related]
38. Inconsistent stimulation of plasma ACTH through corticotropin-releasing factor in a patient with central Cushing's disease due to pituitary adenoma.
Rohrmoser B; Lüdecke DK; Scriba PC
Klin Wochenschr; 1985 May; 63(10):475-7. PubMed ID: 2989613
[TBL] [Abstract][Full Text] [Related]
39. Cushing's syndrome due to ACTH-production of an ovarian carcinoid.
Schlaghecke R; Kreuzpaintner G; Bürrig KF; Juli E; Kley HK
Klin Wochenschr; 1989 Jun; 67(12):640-4. PubMed ID: 2549297
[TBL] [Abstract][Full Text] [Related]
40. Pseudo-Cushing's syndrome: an example of alcohol-induced central disorder in corticotropin-releasing factor-ACTH release?
Proto G; Barberi M; Bertolissi F
Drug Alcohol Depend; 1985 Nov; 16(2):111-5. PubMed ID: 3000719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
